The Rundown cover image

Deep Dive: How Eli Lilly Became the First $1 Trillion Healthcare Company

The Rundown

00:00

Novo Nordisk's missteps and compounding impact

Zaid reviews Novo Nordisk's supply shortages, the rise of compounding pharmacies, and competitive fallout benefiting Lilly.

Play episode from 05:08
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app